Factors Influencing the Utilization of Ketone Bodies by Mouse Adipose Tissue
Overview
Authors
Affiliations
Factors influencing the utilization of ketone bodies by mouse adipose tissue in vitro were studied. Epididymal fat pads can oxidize DL-Beta-hydroxybutyrate-3-(14)C and acetoacetate-3-(14)C to (14)CO(2) as well as convert these compounds to fatty acid-(14)C. An increased output of (14)CO(2) from Beta-hydroxybutyrate-3-(14)C was noted in response to glucose plus insulin, succinate, oxaloacetate, L-asparate, and L-malate. Fatty acid synthesis from Beta-hydroxybutyrate was enhanced by glucose plus insulin, L-aspartate, L-malate, oxaloacetate, and citrate. Nicotinamide stimulated the oxidation of Beta-hydroxybutyrate but not of acetoacetate to CO(2), and did not affect fatty acid synthesis from either ketone body. Nicotinamide increased NAD(+) and NADP(+) levels in epididymal fat pads without affecting the concentration of NADH and NADPH. "Superlipogenesis" caused by fasting the mice for 48 hr and re-feeding them for 24 hr sharply enhanced CO(2) output and lipogenesis from Beta-hydroxybutyrate. The activities of glucose-6-phosphate dehydrogenase, 6-phosphogluconic dehydrogenase, NADP-malic dehydrogenase, and citrate cleavage enzyme from mouse adipose tissue were increased during "superlipogenesis." Free fatty acid release by epididymal fat pads in vitro was slightly increased by Beta-hydroxybutyrate. The relationship of ketone body metabolism and lipogenesis in adipose tissue is discussed.
Derous D, Mitchell S, Green C, Wang Y, Han J, Chen L J Gerontol A Biol Sci Med Sci. 2017; 73(3):279-288.
PMID: 28575190 PMC: 5861923. DOI: 10.1093/gerona/glx101.
Ketone-body production and oxidation in fasting obese humans.
REICHARD Jr G, Owen O, Haff A, Paul P, BORTZ W J Clin Invest. 1974; 53(2):508-15.
PMID: 11344564 PMC: 301493. DOI: 10.1172/JCI107584.
Fatty acid and cholesterol synthesis from specifically labeled leucine by isolated rat hepatocytes.
Mathias M, Sullivan A, Hamilton J Lipids. 1981; 16(10):739-43.
PMID: 7300593 DOI: 10.1007/BF02535341.
Gumaa K, Novello F, McLean P Biochem J. 1969; 114(2):253-64.
PMID: 5810081 PMC: 1184850. DOI: 10.1042/bj1140253.
Willms B, Bottcher M, Wolters V, Sakamoto N, SOLING H Diabetologia. 1969; 5(2):88-96.
PMID: 5373811 DOI: 10.1007/BF01212002.